Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I also think we will see continued dilution after RS
But they can't hold over 9.99% and there was no filling of 5% owner either, so they offload their shares to local bag-holders...
:o)
First trade $1.93.....
I page 27 of the filling:
January 12, 2017 - 4,113,520 shares at $0.36 covered $1,478,318
February 10, 2017 - 15,358,864 shares at $0.20 covered $3,045,817
March 13, 2017 - 41,054,082 shares $0.11. covered $4,417,830
April 10, 2017 - 59,171,335 shares at $0.06 covered $3,621,286
Look at the right, about $12MM
Look at page 27, I'm not sure we done yet (only 12MM reduction in principal):
Pursuant to the terms of the Notes, the Company is required to repay the principal amount thereunder in installments of cash or shares of Common Stock beginning on January 12, 2017 and on each 20th trading day thereafter until the maturity thereof on December 29, 2017. The terms of the Notes require that installment payments in shares of Common Stock be made at a discount to the volume-weighted average trading price during a 20 trading day period prior to such payment. The Company issued shares of Common Stock as installment payments of principal (including certain early repayments at the option of the holders) under the Notes as follows:
Date
Number of
Shares of
Common
Stock Applicable
Conversion
Price Reduction in
Principal
January 12, 2017
4,113,520 $ 0.36 $ 1,478,318
February 10, 2017
15,358,864 $ 0.20 $ 3,045,817
March 13, 2017
41,054,082 $ 0.11 $ 4,417,830
April 10, 2017
59,171,335 $ 0.06 $ 3,621,286
The proposed ratio is 1:50 up to 1:500
Just read the link I posted at page 24.
They are not done yet.
Conversion floor is 0.05 (so that might hold for now), but they still need to make the payments
Number of shares jumped from 118MM to 161MM between March 31 and April 21.
We still don't know if the agreement will cover just new warrant conversion or also the monthly interest payment.
I still hold my HUGE position of 5000 shares ( about $100 LOL), just so I'll keep watching it.
Any run will be a shorting opportunity to the financiers....IMO, until I read otherwise in official filing.
Today filing is another eye opener.
Reasons for the Reverse Stock Split
To enable repayment of the Notes in shares of common stock . The Notes issued in the Note Financing may be converted at the option of the holder thereof. In addition, we are required to make periodic repayments of the principal amount thereof in either shares of common stock or cash. Any repayment of the Notes in shares of common stock is at a discount to the then current trading price, subject to a minimum price floor of $0.05 per share. Our ability to make repayments in shares of common stock is subject to the satisfaction or waiver of certain conditions in the terms of the Notes. Despite the 2016 Reverse Stock Split (as defined below), the Company’s ability to issue shares in payment of installments of principal has been dependent upon waivers of certain of such conditions. If the trading price of our common stock is near or below $0.05 per share, we may not satisfy such conditions, the holders of the Notes may have no economic incentive to waive such conditions and the holders of the Notes may require us to repay the Notes in cash. We may not have sufficient funds for such repayment in cash, which could result in the acceleration of the Notes and foreclosure and repossession of the cash proceeds from the original issuance of the Notes held in a restricted account. Any loss of such funds would materially adversely affect our ability to fund our operations.
Just read:
Page 24 of today filling
LOL.
To all the jokers who are talking about naked shorting.
When the numbers of shares go from 2Million on December 31 to.....
Drum roll (from this morning filling):
an amendment to our Certificate of Incorporation approved by our stockholders on July 19, 2016, we have 500,000,000 shares of Common Stock authorized under our Certificate of Incorporation. However, we have 161,083,213 shares of Common Stock outstanding as of April 21, 2017
All the warrant holders need to do is deliver their new minted shares.
There were 118MM on March 31 and 161MM on April 21.
what next???
:o)
The keyword is "anal"-sys... LOL
This is what DCTH gives to all the gamblers around here who came for a trade and stay as "long term" "investors"
:o)
Not sure yet.
I think the conversion have been stopped (keyword -Think), but they will also have less cash.
I just love all the rumors and the "technical" anal-sys on this board...
:o)
Ooooppppssss...
What you just said?
:o)
And to follow your posting style,
The price is crushing 12.5% in after hours to $1.6....(on a super high volume of 250 shares....)
No, they didn't !
Total institutional holdings is 6.5% which is nothing.
You want to see at least 30%
And your posts are becoming more and more pom-pom posts instead of real information.
Please do a real DD and find both pro and con of the company you are invested in, they are both exist....
Yep.
This is the data as of 12/31.
Soon we will see the 3/31 updates and I hope there will be more institutions.
WOW !!!
The whole 300 shares???
http://www.nasdaq.com/symbol/clrb/after-hours
:o)
You don't have to.
I was following gaps for many years and most are getting closed.
I saw gaps getting close after several years, or after a few days.
of course there are gaps than never get closed (JAZZ, ACAD), but I think the ratio I have seen was over 80% closed.
Time will tell.
You know this is not a public dump site ?
:o)
5000% is based on 50:1 reverse split
:o)
there is a gap from January 23 that might need to be close before moving up...($1.38)
https://finance.yahoo.com/quote/CLRB/history?p=CLRB
And I think the market don't care what you think....
:o)
From the letter:
To fund the ongoing development of our clinical and commercial programs, last year we secured $35 million in committed financing through a securities purchase agreement with two institutional investors, which consisted of senior convertible notes and common stock purchase warrants. This committed financing was the best option available to the Company at that time, and it has provided the resources necessary to advance our clinical development programs toward market approvals where shareholder value ultimately resides. We are regularly evaluating additional alternatives for capital and are committed to acting in the best, long-term interest of our shareholders in all that we do.
Recently, we entered into separate warrant repurchase agreements under which each investor agreed to a Controlled Account Release, in an aggregate amount of $7,876,312, in exchange for cancellation of the Warrants issued under the original agreement. This transaction simplifies our capital structure , and we continue to expect that the cash remaining in the Controlled Accounts after the warrant repurchase will be sufficient to fund our operating activities through the end of 2017.
Some more money needed in 6 month
After it fell down from$30.....
Link to chart
No dilution yet, just increasing incentive plan number of shares (usually given over several years and also vested over several years, not an issue)
But they want to increase authorized to do financing in the future (also reasonable step, since 80MM is still low.....if you don't take into account the several RS they had)
Should have no impact on stock price.
Sure is...
Last year we were removed from the Russell and I said this is a good thing, since the stock will be less manipulated - and as we know, short interest went from over 11MM to below 3MM now.
ATRS will be added back to the Russell this June, but I hope to get a
good deal/buyout due to QST that will mitigate the manipulation.....we will see.
(Current run might also be due to Russell pre-loading)
Looks like we had a 1 cent gap this morning, but pre-market trading was at $2.8, so I'll take it...
http://www.nasdaq.com/symbol/atrs/premarket
:o)
Make your own conclusions.
From 10K:
We do not expect to generate significant revenue for the foreseeable future.
Our entire focus has been on developing, commercializing, and obtaining regulatory authorizations and approvals of CHEMOSAT/Melphalan/HDS and currently we have only developed this system for the treatment of cancers in the liver. If CHEMOSAT/Melphalan/HDS for the treatment of cancers in the liver fails as a commercial product, we have no other products to sell. In addition, since CHEMOSAT is currently only authorized for marketing in the EEA and limited other jurisdictions, if we are unsuccessful in commercializing the product in the EEA and if Melphalan/HDS is not approved in the United States and elsewhere,
we will have no means of generating revenue. In September 2013 , the FDA issued a CRL with respect to our NDA for our Melphalan/HDS. A CRL is issued by the FDA when the review of a file is completed and questions remain that preclude approval of the NDA in its then current form. Accordingly, we do not expect to realiz e any revenues from product sales in the United States in the next several years, if at all. As a result, our revenue sources are, and will remain, extremely limited until our product candidates are approved by the FDA or other additional foreign regulator y agencies and successfully marketed. CHEMOSAT/Melphalan/HDS may not be successful in clinical trials, approved by the FDA or other additional foreign regulatory agency or marketed at any time in the foreseeable future or at all.
Only last 4-5
Most of the interesting stuff is in last year financing....
Also, some of the filling on IHUB is truncated from some reason
Not at all.
He ask where can he find the information about the company and SEC filling is a much better source than message boards...
SEC filling
Even with FDA approval, you'll need money for launch and ramp-up production.
Unless they sign a partner ahead of time, financing was the right thing to do.
And I do like the no warrant financing.
Sure can.
But we need to find out if conversion is over and what is their current cash position.
We should know over the next couple of weeks.
Last time insiders bought was by directors in 2015
In February it was free share grants.
Outstanding are around 130MM when there were about 2MM at the end of December.
Just the facts....
Just bought back at 0.635 some of the shares I sold (for a loss) at 0.68.
I think the warrants is what killing it:
Link to 8K
And the gap is closed !
not that i know....